within Pharmacolibrary.Drugs.V_Various.V08C_MagneticResonanceImagingContrastMedia.V08CA08_GadobenicAcid;

model GadobenicAcid
  extends Pharmacolibrary.Drugs.ATC.V.V08CA08;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>V08CA08</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Gadobenic acid, also known as gadobenate dimeglumine, is a gadolinium-based contrast agent used in magnetic resonance imaging (MRI) to enhance visualization of blood vessels and tissues. It is approved for use in adults and children and is commonly used today for diagnostic imaging.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers following a single intravenous dose.</p><h4>References</h4><ol><li><p>Runge, VM (2017). Critical Questions Regarding Gadolinium Deposition in the Brain and Body After Injections of the Gadolinium-Based Contrast Agents, Safety, and Clinical Recommendations in Consideration of the EMA&#x27;s Pharmacovigilance and Risk Assessment Committee Recommendation for Suspension of the Marketing Authorizations for 4 Linear Agents. <i>Investigative radiology</i> 52(6) 317–323. DOI:<a href=\"https://doi.org/10.1097/RLI.0000000000000374\">10.1097/RLI.0000000000000374</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/28368880/\">https://pubmed.ncbi.nlm.nih.gov/28368880</a></p></li><li><p>Clément, O, et al., &amp; Frija, G (1999). Mechanisms of action of liver contrast agents: impact for clinical use. <i>Journal of computer assisted tomography</i> 23 Suppl 1 S45–S52. DOI:<a href=\"https://doi.org/10.1097/00004728-199911001-00007\">10.1097/00004728-199911001-00007</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/10608397/\">https://pubmed.ncbi.nlm.nih.gov/10608397</a></p></li><li><p>Trunz, LM, et al., &amp; Mitchell, DG (2021). Biliary excretion of gadobenate dimeglumine causing degradation of magnetic resonance cholangiopancreatography (MRCP). <i>Abdominal radiology (New York)</i> 46(2) 562–569. DOI:<a href=\"https://doi.org/10.1007/s00261-020-02686-1\">10.1007/s00261-020-02686-1</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/32743690/\">https://pubmed.ncbi.nlm.nih.gov/32743690</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end GadobenicAcid;
